Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Switzerland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20112
20142
20161
20171
20182
20202
20212
20221
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Applied Molecular Transport2
University Hospital, Basel, Switzerland2
University of Zurich2
Benjamin Misselwitz1
GlaxoSmithKline1
Insel Gruppe AG, University Hospital Bern1
Janssen-Cilag A.G., Switzerland1
Klara M. Pósfay Barbe1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases21
Colitis, Ulcerative10
Crohn Disease8
Irritable Bowel Syndrome2
Colitis1
Esophagitis, Peptic1
Peptic Ulcer1
Pouchitis1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.